Preclinical data demonstrate anti-siglec-15 treatment reduced bone loss and enhanced bone quality in mice with moderate-to-severe osteogenesis imperfecta (oi)

Data presented at the 2023 american society for bone and mineral research (asbmr) annual meeting data presented at the 2023 american society for bone and mineral research (asbmr) annual meeting
NXTC Ratings Summary
NXTC Quant Ranking